Recombined chicken pox virus vaccine rPFV-12LSH9A, preparation process and use thereof
A fowl pox virus, rfpv-12lsh9a technology, applied in recombinant DNA technology, antiviral agents, pharmaceutical formulations and other directions, can solve the problem of destroying the IL-18 binding protein gene and other problems, and achieve the effect of less side effects and increased practicability
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2006-02-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a recombinant fowlpox virus vaccine, in particular to a recombinant fowlpox virus vaccine for expressing H9 subtype avian influenza virus hemagglutinin gene by using a newly identified replication non-essential region of fowlpox virus. Background technique
[0002] Fowlpox Virus (Fowlpox Virus, abbreviated: FPV) is a member of the family Poxviridae and the genus Fowlpoxvirus, and is the largest virus among animal viruses discovered so far. The most unique property is that they replicate in the cytoplasm of infected cells and not in the nucleus. Mature virions are brick-shaped with a size of 250×350nm. The genome of FPV is a double-stranded linear DNA with a size of about 300kb and a molecular weight of about 2-4×10 5 KD, the G+C content reaches 35%, and its DNA is not infectious. Through recombinant DNA technology, more and more researchers have paid attention to the development of poultry genetically engineered recombinant l...
Examples
Embodiment Construction
[0041] The following will be described in detail in conjunction with the implementation examples and the accompanying drawings, but the following implementation examples are to further explain rather than limit the present invention.
[0042] This example relates to the fowlpox virus expression vector p12-18, which was deposited in the General Microbiology Center of China Microbiological Culture Collection Management Committee on June 6, 2005. The preservation number is: CGMCC NO: 1385, and its length is: 10450bp.
[0043] Step 1: Amplification, cloning and sequence analysis of H9 subtype AIV HA gene
[0044] According to the known sequence of H9 subtype AIV HA in our laboratory, PCR amplification primers of H9N2 subtype AIV HA gene were designed. Primers were synthesized by Bao Biological Engineering (Dalian) Co., Ltd.
[0045] Amplification primers of the H9A gene: the 5' end of the upstream primer PH9A1 introduces the BamHI site and Kozak sequence (as shown in the box); th...